Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: Patients in intervention group use a wrist splint as standard treatment, every night and during sleep for 4 weeks. In addition, the topical dill seed oil as the tes
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1-Clinical diagnosis of mild to moderate idiopathic carpal tunnel syndrome by an orthopedic specialist based on history and physical examination as at least 2 symptoms or 1 symptom plus 1 sign (symptoms include: pain, paresthesia, hypoesthesia, numbness and tingling, and signs include: positive Phalen test or Tinel test) 2-Electrodiagnostic evidence of mild to moderate idiopathic carpal tunnel syndrome which includes the following : • SDL > 3/7 m/s2c• SNCV 4/2 m/sec• CL > 2/4 m/sec 3-Voluntary acceptance of the terms of participation in the study and sign the informed consent form
Exclusion criteria
Exclusion criteria: Inability tto fill out the questionnaire. History of sensitivity to dill seed oil Severe idiopathic carpal tunnel syndrome based on electrodiagnostic tests History of severe trauma or fracture of the wrist bones or surgery or injection into the carpal tunnel during the past 6 months Thenar muscle atrophy Rheumatological diseases such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and amyloidosis Pregnant or lactating women Diabetes or hypothyroidism Recent or ongoing inevitable use of corticosteroids or analgesics Coexisting serious illness, such as renal and heart failure life-threatening diseases such as advanced cancer Diseases that can mimic carpal tunnel syndrome, such as multiple sclerosis Use of anticancer drugs and corticosteroids Clinical and electrodiagnostic signs of polyneuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of disease (symptoms and functional status). Timepoint: At the beginning of the enrollment to the study and after 4 weeks of intervention. Method of measurement: Boston Questionnaire (BCTQ).;Electrodiagnostic indices of the median nerve. Timepoint: At the beginning of the enrollment to the study and after 4 weeks of intervention. Method of measurement: Electromyography device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Local side effect. Timepoint: Daily. Method of measurement: Adverse Drug Reaction Reporting Form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Tavakoli
Shiraz University of Medical Sciences
Outcome results
None listed